M. Janiszewska

发表

Classifying the evolutionary and ecological features of neoplasms

Joel s. Brown, K. Pienta, M. Greaves, 2017, Nature Reviews Cancer.

TRPS1 Is a Lineage-Specific Transcriptional Dependency in Breast Cancer

Henry W. Long, W. Sellers, Myles A Brown, 2018, Cell reports.

Collateral lethality between HDAC1 and HDAC2 exploits cancer-specific NuRD complex vulnerabilities

Christopher J. Ott, B. Cravatt, M. Janiszewska, 2022, bioRxiv.

HER2 heterogeneity as a predictor of response to neoadjuvant T-DM1 plus pertuzumab: Results from a prospective clinical trial.

E. Winer, L. Trippa, K. Polyak, 2019, Journal of Clinical Oncology.

Proliferation, phenotype, and cytotoxicity of human lymphocytes isolated from lymph nodes invaded by melanoma cells.

M. Janiszewska, H. Koprowski, M. Nakashima, 1994, Hybridoma.

Determinants of phenotypic intratumor heterogeneity: Integrative approach

M. Janiszewska, A. Marusyk, D. Tabassum, 2015 .

In situ single cell analysis identifies heterogeneity for PIK3CA mutation and HER2 amplification in HER2+ breast cancer

Franziska Michor, Jorge S. Reis-Filho, Carlos L. Arteaga, 2015, Nature Genetics.

Cell adhesion in cancer: Beyond the migration of single cells

M. Janiszewska, T. Izard, M. C. Primi, 2020, The Journal of Biological Chemistry.

Intratumor Heterogeneity: The Rosetta Stone of Therapy Resistance.

K. Polyak, M. Janiszewska, A. Marusyk, 2020, Cancer cell.

Response and resistance to BET bromodomain inhibitors in triple negative breast cancer

James E. Bradner, Jason S. Carroll, X. Shirley Liu, 2015, Nature.

IMPs: an RNA-binding protein family that provides a link between stem cell maintenance in normal development and cancer

Nicolò Riggi, I. Stamenkovic, M. Janiszewska, 2016, Genes & development.

Imp2 controls oxidative phosphorylation and is crucial for preserving glioblastoma cancer stem cells.

Nicolò Riggi, J. Auwerx, P. Provero, 2012, Genes & development.

EZH2 is essential for glioblastoma cancer stem cell maintenance.

Nicolò Riggi, P. Provero, I. Stamenkovic, 2009, Cancer research.

The microcosmos of intratumor heterogeneity: the space-time of cancer evolution

M. Janiszewska, 2019, Oncogene.

Let-7a Is a Direct EWS-FLI-1 Target Implicated in Ewing's Sarcoma Development

Nicolò Riggi, P. Provero, I. Stamenkovic, 2011, PloS one.

Single-cell genetic heterogeneity linked to immune infiltration in glioblastoma

Thomas O. McDonald, M. Janiszewska, F. Michor, 2021, bioRxiv.

The impact of tumor epithelial and microenvironmental heterogeneity on treatment responses in HER2+ breast cancer

P. Spellman, K. Chin, J. Gray, 2021, JCI insight.

A confetti trail of tumour evolution

K. Polyak, M. Janiszewska, 2018, Nature Cell Biology.

Clonal evolution in cancer: a tale of twisted twines.

Kornelia Polyak, K. Polyak, M. Janiszewska, 2015, Cell stem cell.

The RNA Binding Protein IMP2 Preserves Glioblastoma Stem Cells by Preventing let-7 Target Gene Silencing.

R. Paro, Nicolò Riggi, P. Provero, 2016, Cell reports.

YAP-Mediated Recruitment of YY1 and EZH2 Represses Transcription of Key Cell-Cycle Regulators

J. Kissil, M. Janiszewska, R. Witwicki, 2020, Cancer Research.

Adult precision medicine: learning from the past to enhance the future

Duane A. Mitchell, Wolfgang Wick, Ashley Ghiaseddin, 2020, Neuro-oncology advances.

EWS-FLI-1 modulates miRNA145 and SOX2 expression to initiate mesenchymal stem cell reprogramming toward Ewing sarcoma cancer stem cells.

Nicolò Riggi, P. Provero, I. Stamenkovic, 2010, Genes & development.

Epigenetic Features of Human Mesenchymal Stem Cells Determine Their Permissiveness for Induction of Relevant Transcriptional Changes by SYT-SSX1

P. Provero, I. Stamenkovic, M. Janiszewska, 2009, PloS one.

Spatial Proximity to Fibroblasts Impacts Molecular Features and Therapeutic Sensitivity of Breast Cancer Cells Influencing Clinical Outcomes.

S. Hilsenbeck, R. Schiff, Y. Nikolsky, 2016, Cancer research.

Subclonal cooperation drives metastasis by modulating local and systemic immune microenvironments

O. Cohen, K. Polyak, M. Janiszewska, 2019, Nature Cell Biology.

Single-cell heterogeneity of EGFR and CDK4 co-amplification is linked to immune infiltration in glioblastoma

Thomas O. McDonald, M. Janiszewska, F. Michor, 2023, Cell reports.

stem cells cancermesenchymal stem cell reprogramming toward Ewing sarcoma expression to initiate SOX 2 EWS-FLI-1 modulates miRNA 145 and Material Supplemental

Nicolò Riggi, P. Provero, I. Stamenkovic, 2010 .

Transportin Regulates Nuclear Import of CD44

I. Stamenkovic, M. Janiszewska, C. Fusco, 2010, The Journal of Biological Chemistry.

A confetti trail of tumour evolution

K. Polyak, M. Janiszewska, 2018, Nature Cell Biology.

Tumor heterogeneity: the Lernaean hydra of oncology?

F. Beca, K. Polyak, M. Janiszewska, 2014, Oncology.

Collateral lethality between HDAC1 and HDAC2 exploits cancer-specific NuRD complex vulnerabilities

Christopher J. Ott, B. Cravatt, M. Janiszewska, 2023, Nature Structural & Molecular Biology.

EZH2 is essential for glioblastoma cancer stem cell maintenance.

Nicolò Riggi, P. Provero, I. Stamenkovic, 2009, Cancer research.

Response and resistance to BET bromodomain inhibitors in triple negative breast cancer

Clifford A. Meyer, Henry W. Long, Christopher J. Ott, 2015, Nature.

Transportin Regulates Nuclear Import of CD44

I. Stamenkovic, M. Janiszewska, C. Fusco, 2010, The Journal of Biological Chemistry.

Cell sorting based on single nucleotide variation enables characterization of mutation-dependent transcriptome and chromatin states

M. Janiszewska, Oszkar Szentirmai, Roberto Salatino, 2024, bioRxiv.

Spatial analysis of recurrent glioblastoma reveals perivascular niche organization

Chandler D. Gatenbee, Sandhya Prabhakaran, M. Janiszewska, 2024, JCI insight.